Hikma Pharmaceuticals (HIK)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1185.00p Today's change: +0.25%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1185.00p 5 day change: +2.6%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1185.00p 6 month change: -35.77%

Contact details

Address: 13 Hanover Square, London, United Kingdom
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: www.hikma.com

Company information

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals announced it expects revenue to come in at the lower end of its forecast, deepening concerns [...]

17 August 2017
Shares
5
Views
538

The London Stock Exchange has confirmed that security giant G4S and real estate investment trust Segro have been [...]

31 May 2017
Shares
32
Views
1,896

Security giant G4S and property firm Segro are poised to join the UK’s stock market elite next month, with the [...]

30 May 2017
Shares
1
Views
1,090

Shares in Hikma Pharmaceuticals fell by as much as 7.5 per cent in early trading today after the company cut [...]

19 May 2017
Shares
6
Views
1,028

Hikma Pharmaceuticals' shares fell nearly nine per cent today after its asthma drug's second application was [...]

11 May 2017
Views
916

Hikma Pharmaceuticals was the top gainer on the FTSE 100 today as its profit drop was smaller than expected. [...]

15 March 2017
Views
557

FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]

10 November 2016
Shares
2
Views
536

Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]

9 November 2016
Shares
5
Views
664

The FTSE 100 ended the day at 6,894.6 points - 2.2 per cent higher, and within spitting distance of that 7,000 [...]

2 September 2016
Views
512

Hikma Pharmaceuticals is set to enter the FTSE 100 index as satellite firm Inmarsat drops to the FTSE 250. [...]

1 June 2016
Shares
1
Views
269

Hikma Pharmaceuticals’ share price plummeted 20 per cent this morning, after the drugmaker slashed its offer [...]

10 February 2016
Views
393

London-listed Hikma Pharmaceuticals received a boost this morning, after the FDA said it no longer had an issue [...]

18 November 2015
Views
266

The shake-up revealed as a result of the quarterly review of the FTSE 100 and 250 takes effect this morning. [...]

23 March 2015
Shares
3
Views
1,523

Tullow Oil and Afren are likely to slip out of their respective FTSE indexes after this week's quarterly review. [...]

2 March 2015
Views
3,549

Content tagged with "Hikma Pharmaceuticals"